Mathematical model for BCG-based treatment of type 1 diabetes
From MaRDI portal
Publication:6156474
DOI10.1016/j.physa.2023.128891OpenAlexW4377101861MaRDI QIDQ6156474
Teddy Lazebnik, Svetlana Bunimovich-Mendrazitsky, Alex Kiselyov
Publication date: 13 June 2023
Published in: Physica A (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.physa.2023.128891
BCG treatment for T1Dclinical in-silico experimentsdiet-based treatment protocolNOD mice mathematical modeloptimal treatment analysis
Cites Work
- Unnamed Item
- Unnamed Item
- Stability analysis of delayed immune response BCG infection in bladder cancer treatment model by stochastic perturbations
- \textit{BCG} and \(IL-2\) model for bladder cancer treatment with fast and slow dynamics based on SPVF method -- stability analysis
- Additional extension of the mathematical model for BCG immunotherapy of bladder cancer and its validation by auxiliary tool
- Asymptotic equilibrium and stability of fuzzy differential equations
- Mathematical model of BCG immunotherapy in superficial bladder cancer
- Existence of Solutions for Nonlinear Implicit Differential Equations: An Equilibrium Problem Approach
- The MATLAB ODE Suite
- Solving Index-1 DAEs in MATLAB and Simulink
- Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease?
- EXISTENCE AND STABILITY RESULTS FOR COUPLED SYSTEM OF FRACTIONAL DIFFERENTIAL EQUATIONS INVOLVING AB-CAPUTO DERIVATIVE
- EXISTENCE RESULTS FOR MULTI-TERM FRACTIONAL DIFFERENTIAL EQUATIONS WITH NONLOCAL BOUNDARY CONDITIONS INVOLVING ATANGANA–BALEANU DERIVATIVE
This page was built for publication: Mathematical model for BCG-based treatment of type 1 diabetes